Ultrasound contrast agents and prostate cancer;Ultraschallkontrastmittel und prostatakarzinom

Radiologe

Volumn 45, Issue 6, 2005, Pages 544-551

  Frauscher, F ^a   Pallwein, L ^a   Klauser, A ^a   Berger, A P ^a   Koppelstaetter, F ^a   Gradl, J ^a   Schurich, M ^a   Bektic, J ^a   Pinggera, G M ^a   Halpern, E J ^b   Horninger, W ^a   Bartsch, G ^a   Zur Nedden, D ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Doppler sonography; Prostate; Prostatic carcinoma; Ultrasound; Ultrasound contrast agents

Indexed keywords

ECHO CONTRAST MEDIUM; PROSTATE SPECIFIC ANTIGEN; SONOVUE;

ANTIGEN DETECTION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CONTRAST ENHANCEMENT; DIGITAL RECTAL EXAMINATION; FREQUENCY ANALYSIS; HUMAN; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VASCULARIZATION;

BIOPSY; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MICROBUBBLES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY;

EID: 21744448810     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-005-1193-2     Document Type: Review

References (30)

1. American Cancer Society (2004) Cancer facts and figures. American Cancer Society, Atlanta
2. Bartsch G, Horninger W, Klocker H et al. (2001)Tyrol Prostate Cancer Screening Group. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58:417-424
3. Basude R, Wheatley MA (2001) Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages. Ultrasonics 39:437-444
4. Bogers HA, Sedelaar JPM, Beerlage HP et al. (1999) Contrast enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97-104
5. Bouakaz A, Frigstad S, Ten Cate FJ, De Jong N (2002) Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound Med Biol 28:59-68
6. Chang JJ, Shinohara K, Bhargava V, Presti JC jr (1998) Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160:2111-2114
7. Cookson MS (2000) Update on transrectal ultrasound-guided needle biopsy of the prostate. Mol Urol 4:93-97
8. Cornud F, Belin X, Piron D et al. (1997) Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49:709-715
9. Cvetkovic D, Movsas B, Dicker AP et al. (2001) Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 57:821-825
10. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72
11. Engelbrecht MR, Barentsz JO, Jager GJ et al. (2000) Prostate cancer staging using imaging. BJU Int 86:123-134
12. Eskew LA, Bare RL, McCullough DL (1997) Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157:199-202
13. Forsberg F, Merton DA, Liu JB et al. (1998) Clinical applications of ultrasound contrast agents. Ultrasonics 36(1-5):695-701
14. Frauscher F, Klauser A, Halpern EJ, Horninger W, Bartsch G (2001) Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 357:1849-1850
15. Frauscher F, Klauser A, Volgger H et al. (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167:1648-1652
16. Frauscher F, Klauser A, Berger AP et al. (2003) The value of ultrasound (US) in the diagnosis of prostate cancer. Radiologe 43:455-463
17. Goossen TEB, Sedelaar JPM, De la Rosette JJMCH, Van Leenders GJLH, Wijkstra H (2002) The value of dynamic contrast enhanced power Doppler ultrasound in the localization of prostate carcinoma. Eur Urol 1 [suppl 1]:91;abstr 355
18. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174:623-637
19. Halpern EJ, Verkh L, Forsberg Fetal. (2000) Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol 174:1575-1580
20. Halpern EJ, Rosenberg M, Cornelia LG (2001) Prostate cancer: contrast-enhanced US for detection. Radiology 219:219-225
21. Heynemann H, Jenderka KV, Zacharias M, Fornara P (2004) New techniques in uro-sonography. Urologe-A 43:1362-1370
22. Kelly IM, Lees WR, Rickards D (1993) Prostate cancer and the role of color Doppler US. Radiology 189:153-156
23. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388-392
24. Norberg M, Egevad L, Holmberg L et al. (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562-566
25. Rifkin MD (1997) Ultrasound of the prostate, 2nd edn. Lippincott-Raven, Philadelphia
26. Scardino PT, Weaver R, Hudson MA (1992) Early detection of prostate cancer. Hum Pathol 23:211-222
27. Sedelaar JP, Van Leenders GJ, Hulsbergen-Van De Kaa CA et al. (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 40:285-293
28. Siegal JA, Yu E, Brawer MK (1995) Topography of neovascularity in human prostate carcinoma. Cancer 75:2545-2551
29. Strohmeyer D, Frauscher F, Klauser A et al. (2001) Contrast-enhanced transrectal color Doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res 21:2907-2913
30. Unal D, Sedelaar JP, Aarnink RG et al. (2000) Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 86:58-64